Today, I realize that this was all smoke and mirrors and that I have been wrong.
I especially like the part where the office furniture is put under scrutiny. That was an eye opener for me. Never would I have gotten the ida of researching such a vital and important part of the business. I now fear that the latest surge in share price was not due to the FDA granting Brilacidin QIDP designation but merely a matter of speculation based on an unrealistic valuation of the 25 hight adjustable desks and the almost new canteen vending machine.